Hinge Health, Inc. (HNGE)

NYSE: HNGE · Real-Time Price · USD

89.26

-2.05 (-2.25%)

Sep 10, 2026, 2:57 PM EDT - Market open

Hinge Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	109.07	-528.26	-11.93	-108.14
Depreciation & Amortization	2.02	2.13	2.35	2.13
Other Amortization	64.79	49.67	33.51	23.84
Loss (Gain) From Sale of Investments	0.74	0.36	0.54	-10.76
Stock-Based Compensation	82.8	643.01	0.74	1.65
Provision & Write-off of Bad Debts	1.89	3.06	5.41	4.86
Other Operating Activities	3.55	3.49	4.88	13.11
Change in Accounts Receivable	-28.03	-26.63	-1.34	-23.13
Change in Inventory	-2.78	-4.76	0.61	10.57
Change in Accounts Payable	25	29.41	-10.98	11.56
Change in Unearned Revenue	141.33	83.22	77.16	35.97
Change in Other Net Operating Assets	-109.6	-83.25	-51.95	-25.56
Operating Cash Flow	290.79	171.44	49	-63.91
Operating Cash Flow Growth	216.46%	249.87%	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Capital Expenditures	-0.67	-0.71	-1.04	-1.98
Cash Acquisitions	-	-4	-	-
Sale (Purchase) of Intangibles	-6.2	-5.36	-2.73	-2.64
Investment in Securities	-12.89	-103.7	22.09	6.12
Investing Cash Flow	-19.75	-113.76	18.31	1.5

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Issuance of Common Stock	17.23	265.2	0.61	0.49
Repurchase of Common Stock	-239.28	-360.26	-	-
Other Financing Activities	-0.29	-55.42	-2.81	-3.49
Financing Cash Flow	-222.34	-150.47	-2.2	-3

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Cash Flow	48.69	-92.79	65.11	-65.41

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Free Cash Flow	290.12	170.73	47.96	-65.89
Free Cash Flow Growth	218.23%	255.97%	-	-
Free Cash Flow Margin	40.29%	29.04%	12.29%	-22.51%
Free Cash Flow Per Share	3.60	3.13	3.54	-5.06
Levered Free Cash Flow	299.65	406.8	68.94	-
Unlevered Free Cash Flow	299.65	406.8	68.94	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash Income Tax Paid	2.71	1.56	-	-
Change in Working Capital	25.93	-2.01	13.5	9.41

SEC Filings: 10-K · 10-Q